Literature DB >> 14742215

In vitro activities of new antimicrobials against Nocardia brasiliensis.

Lucio Vera-Cabrera1, Eva Gonzalez, Sung H Choi, Oliverio Welsh.   

Abstract

The in vitro sensitivities of 30 strains of Nocardia brasiliensis to DA-7867, gatifloxacin, moxifloxacin, and BMS-284756 (garenoxacin) were determined using the broth microdilution method. All N. brasiliensis strains were sensitive to these antimicrobials. The most active drug in vitro was DA-7867, with a MIC at which 90% of the isolates tested were inhibited of 0.03 micro g/ml and a MIC at which 50% of the isolates tested were inhibited of 0.06 micro g/ml.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14742215      PMCID： PMC321515          DOI： 10.1128/AAC.48.2.602-604.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

Review 1.  Mycetoma. Current concepts in treatment.

Authors:  O Welsh
Journal:  Int J Dermatol       Date:  1991-06       Impact factor: 2.736

2.  The in vitro activity of BMS-284756, a new des-fluorinated quinolone.

Authors:  T M A Weller; J M Andrews; G Jevons; R Wise
Journal:  J Antimicrob Chemother       Date:  2002-01       Impact factor: 5.790

Review 3.  Linezolid.

Authors:  D Clemett; A Markham
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

4.  In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci.

Authors:  G A Noskin; F Siddiqui; V Stosor; D Hacek; L R Peterson
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

5.  In vitro activities of linezolid against multiple Nocardia species.

Authors:  B A Brown-Elliott; S C Ward; C J Crist; L B Mann; R W Wilson; R J Wallace
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

6.  In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis.

Authors:  L Vera-Cabrera; A Gómez-Flores; W G Escalante-Fuentes; O Welsh
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

7.  Clinical experience with linezolid for the treatment of nocardia infection.

Authors:  Edina H Moylett; Susan E Pacheco; Barbara A Brown-Elliott; Tracy R Perry; E Stephen Buescher; Mary C Birmingham; Jerome J Schentag; Joseph F Gimbel; Aaron Apodaca; Margot A Schwartz; Robert M Rakita; Richard J Wallace
Journal:  Clin Infect Dis       Date:  2003-01-13       Impact factor: 9.079

8.  Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetoma.

Authors:  O Welsh; E Sauceda; J Gonzalez; J Ocampo
Journal:  J Am Acad Dermatol       Date:  1987-09       Impact factor: 11.527

9.  [Epidemiology of mycetoma in Mexico: study of 2105 cases].

Authors:  R López Martínez; L J Méndez Tovar; P Lavalle; O Welsh; A Saúl; E Macotela Ruíz
Journal:  Gac Med Mex       Date:  1992 Jul-Aug       Impact factor: 0.302

Review 10.  Oxazolidinones: a review.

Authors:  D I Diekema; R N Jones
Journal:  Drugs       Date:  2000-01       Impact factor: 11.431
View more
  12 in total

1.  Nocardia mexicana sp. nov., a new pathogen isolated from human mycetomas.

Authors:  Verónica Rodríguez-Nava; Andrée Couble; Claudie Molinard; Horacio Sandoval; Patrick Boiron; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

2.  In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid.

Authors:  Lucio Vera-Cabrera; Mayra Paola Campos-Rivera; Wendy G Escalante-Fuentes; Michael J Pucci; Jorge Ocampo-Candiani; Oliverio Welsh
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

3.  In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis.

Authors:  Lucio Vera-Cabrera; Eva Gonzalez; Adrian Rendon; Jorge Ocampo-Candiani; Oliverio Welsh; Victor M Velazquez-Moreno; Sung Hak Choi; Carmen Molina-Torres
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

4.  In vitro susceptibility of Mycobacterium tuberculosis clinical isolates to garenoxacin and DA-7867.

Authors:  Lucio Vera-Cabrera; Jorge Castro-Garza; Adrian Rendon; Jorge Ocampo-Candiani; Oliverio Welsh; Sung Hak Choi; Kym Blackwood; Carmen Molina-Torres
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

5.  In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria.

Authors:  Lucio Vera-Cabrera; Barbara A Brown-Elliott; Richard J Wallace; Jorge Ocampo-Candiani; Oliverio Welsh; Sung Hak Choi; Carmen A Molina-Torres
Journal:  Antimicrob Agents Chemother       Date:  2006-10-02       Impact factor: 5.191

6.  In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods.

Authors:  Emilia Cercenado; Mercedes Marín; Mónica Sánchez-Martínez; Oscar Cuevas; José Martínez-Alarcón; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

7.  In vitro activities of the new antitubercular agents PA-824 and BTZ043 against Nocardia brasiliensis.

Authors:  Lucio Vera-Cabrera; Mayra Paola Campos-Rivera; Norma Alejandra Gonzalez-Martinez; Jorge Ocampo-Candiani; Stewart T Cole
Journal:  Antimicrob Agents Chemother       Date:  2012-04-23       Impact factor: 5.191

8.  Efficacy of ciprofloxacin and moxifloxacin against Nocardia brasiliensis in vitro and in an experimental model of actinomycetoma in BALB/c mice.

Authors:  Brenda Edith Chacon-Moreno; Oliverio Welsh; Norma Cavazos-Rocha; Maria de la Luz Salazar-Cavazos; Hector Gerardo Garza-Lozano; Salvador Said-Fernandez; Jorge Ocampo-Candiani; Lucio Vera-Cabrera
Journal:  Antimicrob Agents Chemother       Date:  2008-10-13       Impact factor: 5.191

9.  In vivo therapeutic effect of gatifloxacin on BALB/c mice infected with Nocardia brasiliensis.

Authors:  Alejandra Daw-Garza; Oliverio Welsh; Salvador Said-Fernández; Hector Gerardo Lozano-Garza; Noemi Waksman de Torres; Norma Cavazos Rocha; Jorge Ocampo-Candiani; Lucio Vera-Cabrera
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

10.  Therapeutic effect of a novel oxazolidinone, DA-7867, in BALB/c mice infected with Nocardia brasiliensis.

Authors:  Lucio Vera-Cabrera; Alejandra Daw-Garza; Salvador Said-Fernández; Hector Gerardo Lozano-Garza; Noemi Waksman de Torres; Norma Cavazos Rocha; Jorge Ocampo-Candiani; Sung-Hak Choi; Oliverio Welsh
Journal:  PLoS Negl Trop Dis       Date:  2008-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.